# Portfolio

Last updated: 2026-08-03 (intraday risk-reduction routine, ~13:14 ET) —
reconciled against Alpaca, no discrepancy this run (single MSFT position,
matches record). Risk-reduction-only run: no trades placed, snapshot/status
refreshed but benchmark table below is last updated by the daily-close
routine.

**Alpaca is the source of truth.** This file is a human-readable mirror with
the reasoning attached, which the broker does not store. If they disagree,
trust Alpaca, fix this file, and log why they drifted.

## Snapshot

| Field | Value |
|-------|-------|
| Mode | PAPER |
| Equity | $100,068.85 |
| Cash | $99,000.00 |
| Open positions | 1 |
| New positions this week | 0 (per Alpaca `new_positions_this_week`) |

## Holdings

### MSFT — 1.07% of equity
- **Entry:** 2026-07-31, $456.70 avg, $1,000 notional (2.189599299 sh)
- **Thesis:** Azure/cloud revenue growth is accelerating (40% -> 43% YoY,
  FQ3 -> FQ4 FY26) on real reported numbers, not capex narrative; EPS
  growth (FY26 GAAP diluted EPS $17.95) is outrunning the post-earnings
  price move, so the ~25.2x trailing P/E is near the bottom of MSFT's own
  5-year range despite the stock being up double digits post-print.
- **Invalidation:** Azure YoY growth decelerates back below ~35% in the
  FQ1 FY27 print, commercial RPO growth reverses meaningfully, or capex
  guidance is cut in a way that reads as AI-monetization doubt rather than
  discipline.
- **Catalyst:** already happened (FY26 Q4 earnings, reported 2026-07-29);
  next checkpoint is the FQ1 FY27 print.
- **Stop:** 10% trailing stop live, order id
  `cee441de-48ae-4e48-9cc2-d6482a4c3b0a`, covers 2 of 2.19 whole shares
  (Alpaca does not accept trailing stops on the fractional remainder).
  Confirmed still open as of 2026-08-03 intraday check (~13:14 ET): status
  `new`, hwm $491.35, stop price $442.215.
- **Status:** on track — up 6.88% unrealized ($488.12 vs $456.70 entry) as of
  2026-08-03 intraday risk-reduction check. Checked for thesis-breaking news
  via Perplexity (unrestricted query, since this is a same-day news
  sanity-check rather than a fundamentals claim) for anything new since the
  2026-07-29 FY26 Q4 print through today: no new 8-K, no new IR release, no
  lawsuit, no regulatory action, no executive change — today's coverage is
  recap of the known earnings beat, not new information. Thesis unchanged and
  intact. Well inside the -7%/-15% sell triggers and the 5%-of-equity trim
  threshold (~1.07% of equity).

Format for each position, one block:

### TICKER — 0.0% of equity
- **Entry:** date, avg price, size
- **Thesis:** one sentence, falsifiable
- **Invalidation:** the specific thing that would make this wrong
- **Catalyst:** what and roughly when
- **Stop:** trailing % if set
- **Status:** on track / watching / trimming

## Benchmark

| Date | Portfolio | SPY | Delta |
|------|-----------|-----|-------|
| 2026-07-30 | 0.00% | +1.65% | -1.65% |
| 2026-07-31 | +0.02% | +0.70% | -0.68% |

Since-inception delta (2026-07-29 close baseline, when the account was first
funded at $100,000 with 0 positions, SPY `prev_close` 729.57): portfolio
+0.02% ($100,000 → $100,015.70), SPY +2.36% (729.57 → 746.79 per
`alpaca.py quote SPY` at this close), delta **-2.34%**. The one MSFT
position (bought 2026-07-31) is up on its own terms (+1.57% since entry),
but the account has been mostly cash (99%+) through a period where SPY ran
up meaningfully — the delta is a cash-drag story so far, not a stock-picking
loss. Nothing here says slow the buy criteria down; it's one data point over
two trading days.
